tradingkey.logo

Surmodics Inc

SRDX
查看詳細走勢圖
42.980USD
0.000
收盤 12/24, 13:00美東報價延遲15分鐘
614.53M總市值
虧損本益比TTM

Surmodics Inc

42.980
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

0.00%

1月

0.00%

6月

+48.21%

今年開始到現在

+8.54%

1年

+8.76%

查看詳細走勢圖

TradingKey Surmodics Inc股票評分

單位: USD 更新時間: 2025-11-19

操作建議

Surmodics Inc當前公司基本面數據相對健康,當前估值合理,機構持股佔比非常高,近一個月多位分析師給出公司評級為賣出。最高目標價max_target_price。近一個月,市場表現非常差,但公司基本面和技術面得分較高。

Surmodics Inc評分

相關信息

行業排名
77 / 209
全市場排名
183 / 4596
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
43.000
目標均價
+47.26%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Surmodics Inc亮點

亮點風險
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
業績高增長
公司營業收入穩步增長,連續3年增長26.14%
估值合理
公司最新PE估值0.00,處於3年歷史合理位
機構減倉
最新機構持股12.95M股,環比減少24.21%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉1.13K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.62

Surmodics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Surmodics Inc簡介

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
公司代碼SRDX
公司Surmodics Inc
CEOHance (Robert B)
網址https://www.surmodics.com/

常見問題

Surmodics Inc(SRDX)的當前股價是多少?

Surmodics Inc(SRDX)的當前股價是 42.980。

Surmodics Inc 的股票代碼是什麼?

Surmodics Inc的股票代碼是SRDX。

Surmodics Inc股票的52週最高點是多少?

Surmodics Inc股票的52週最高點是42.890。

Surmodics Inc股票的52週最低點是多少?

Surmodics Inc股票的52週最低點是25.870。

Surmodics Inc的市值是多少?

Surmodics Inc的市值是614.53M。

Surmodics Inc的淨利潤是多少?

Surmodics Inc的淨利潤為-11.54M。

現在Surmodics Inc(SRDX)的股票是買入、持有還是賣出?

根據分析師評級,Surmodics Inc(SRDX)的總體評級為--,目標價格為43.000。

Surmodics Inc(SRDX)股票的每股收益(EPS TTM)是多少

Surmodics Inc(SRDX)股票的每股收益(EPS TTM)是-1.237。
KeyAI